The N6‐Methyladenosine‐Modified CIT Promotes Uterine Corpus Endometrial Carcinoma Progression by Inhibiting the Hippo Signaling Pathway
Immunology & Cell Biology · 2026
DOI: 10.1111/imcb.70152 ↗At a glance
Journal article in Immunology & Cell Biology, 2026. Written by Yuehong Tong and 4 co-authors. Institution: Department of Gynaecology, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, Zhejiang, China. Major MEDLINE topics: Endometrial Neoplasms, Protein Serine-Threonine Kinases, Adenosine. 33 references. The full text is freely available in PubMed Central. Funded by: the Key Project of Social Development Category in Jinhua Science and Technology Plan.
Abstract (original language)
This study investigates the role of CIT gene in uterine corpus endometrial carcinoma (UCEC) progression, focusing on its regulation by m6A methylation. Bioinformatics and experimental analyses (EdU, colony formation assay, Dot blot, MeRIP‐PCR, RNA pull‐down, qRT‐PCR, Western Blotting, apoptosis assay) revealed that CIT was significantly overexpressed in UCEC. Mechanistically, we found that the m6A writer RBM15‐mediated CIT mRNA methylation, which was then recognized by the reader IGF2BP1 to enhance CIT mRNA stability and expression. Consequently, this m6A‐mediated upregulation of CIT inhibited the Hippo signaling pathway, ultimately suppressing apoptosis and promoting malignant proliferation in UCEC. These findings elucidated a novel RBM15/IGF2BP1‐CIT‐Hippo axis, providing new theoretical insights and potential therapeutic targets for UCEC.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Gynaecology, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, Zhejiang, China.
- Department of Gynaecology, Jinhua Maternal and Child Health Care Hospital, Jinhua, Zhejiang, China.
- Medical Molecular Biology Laboratory, Medical College, Jinhua University of Vocational Technology, Jinhua, Zhejiang, China.
ORCID profiles: Xiaoyan Fu
Funding
- the Key Project of Social Development Category in Jinhua Science and Technology Plan
Cite
APA
Tong, Y., Xu, L., Sun, Y., Zhang, K., & Fu, X. (2026). The N6‐Methyladenosine‐Modified CIT Promotes Uterine Corpus Endometrial Carcinoma Progression by Inhibiting the Hippo Signaling Pathway. Immunology & Cell Biology. https://doi.org/10.1111/imcb.70152
Vancouver
Tong Y, Xu L, Sun Y, Zhang K, Fu X. The N6‐Methyladenosine‐Modified CIT Promotes Uterine Corpus Endometrial Carcinoma Progression by Inhibiting the Hippo Signaling Pathway. Immunology & Cell Biology. 2026. doi:10.1111/imcb.70152
BibTeX
@article{Tong2026,
author = {Tong, Yuehong and Xu, Lili and Sun, YiQun and Zhang, Keke and Fu, Xiaoyan},
title = {The N6‐Methyladenosine‐Modified CIT Promotes Uterine Corpus Endometrial Carcinoma Progression by Inhibiting the Hippo Signaling Pathway},
journal = {Immunology & Cell Biology},
year = {2026},
doi = {10.1111/imcb.70152}
}
EUVIMED